Generics and API Intelligence

"I need to secure early, exclusive sources of API supply."

With new markets opening throughout the developing world, an ageing population in established markets, governments and employers striving to reign in healthcare expenditure, and so many blockbuster drugs edging toward patent expiry, the generic industry offers phenomenal opportunities.

However, generic dose prices are falling in many countries, squeezing margins. The number of players is increasing, while low-cost active ingredients from India and China further depress prices.  

So how do you keep ahead of your competitors? How do you chase down the drugs to target, source APIs, and identify licensing and acquisitioning opportunities?

We track, monitor and expertly analyze ongoing developments in thousands of launched products and companies operating in the global pharmaceutical market.

By incorporating the unique strategic intelligence and powerful competitive analysis that is only available from Thomson Reuters, we could ensure you’ll be first to find the drug, first to find the niche, first to make the deal, and first to get to market.

If you’re an innovator, we can give you up to seven years’ advance warning of patent challenges and attempts at circumvention. Our powerful competitive intelligence and analytical tools can help you identify, assess and track the earliest signs of generic competition.

For Generics & API Manufacturers

For Innovators

API manufacturers

If you are an API manufacturer and would like to update information about your product line and manufacturing capabilities, please fill out the API Manufacturers Form.



Key Event

Join Thomson Reuters at CBI's Pharmaceutical Congress on Paragraph IV Disputes. It will be held on October 15 — 16 in Philadelphia, PA at the Marriott hotel.
NAVIGATING REGULATIONS AND ENFORCEMENT TRENDS TO INCREASE PREPAREDENESS AND OPTIMIZE PARAGRAPH IV STRATEGIES








Who can benefit

  • Generic drugs companies
  • Competitive intelligence professionals
  • Intellectual property professionals
  • Licensing and business development
  • API manufacturers
  • Regulatory affairs managers
  • Brand managers/marketing

Additional Resources


OUR OVERVIEW OF THE MOST SIGNIFICANT GAME-PLAY IN THE US GENERICS MARKET. Sign up for your free subscription


Essential Solutions